NZ332641A - method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease - Google Patents

method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease

Info

Publication number
NZ332641A
NZ332641A NZ332641A NZ33264197A NZ332641A NZ 332641 A NZ332641 A NZ 332641A NZ 332641 A NZ332641 A NZ 332641A NZ 33264197 A NZ33264197 A NZ 33264197A NZ 332641 A NZ332641 A NZ 332641A
Authority
NZ
New Zealand
Prior art keywords
lsd
assaying
enzyme
protein
detecting
Prior art date
Application number
NZ332641A
Other languages
English (en)
Inventor
Peter J Meikle
Douglas A Brooks
John J Hopwood
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Publication of NZ332641A publication Critical patent/NZ332641A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NZ332641A 1996-05-17 1997-05-16 method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease NZ332641A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN9917A AUPN991796A0 (en) 1996-05-17 1996-05-17 Early detection of lysosomal storage disorders
PCT/AU1997/000304 WO1997044668A1 (en) 1996-05-17 1997-05-16 Early detection of lysosomal storage disorders

Publications (1)

Publication Number Publication Date
NZ332641A true NZ332641A (en) 2000-05-26

Family

ID=3794228

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ332641A NZ332641A (en) 1996-05-17 1997-05-16 method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease

Country Status (10)

Country Link
US (2) US6759189B1 (enExample)
EP (1) EP1021725B1 (enExample)
JP (3) JP3837711B2 (enExample)
AT (1) ATE426169T1 (enExample)
AU (1) AUPN991796A0 (enExample)
CA (2) CA2253875C (enExample)
DE (1) DE69739317D1 (enExample)
IL (1) IL127033A (enExample)
NZ (1) NZ332641A (enExample)
WO (1) WO1997044668A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002543425A (ja) * 1999-04-30 2002-12-17 ザ ナタン エス． クライン インスティテュート フォー サイキアトリック リサーチ アルツハイマー病の治療のための化合物の同定法
US7090987B1 (en) 1999-04-30 2006-08-15 Nixon Ralph A Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia
NZ543309A (en) 2003-03-31 2008-12-24 Womens & Childrens Hospital Multiplex screening for lysosomal storage disorders (LSDs)
US7615224B2 (en) * 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
ES2301280A1 (es) * 2005-05-16 2008-06-16 Fina Biotech S.L.U. Metodo para diagnosticar la enfermedad de alzheimer.
WO2007136782A2 (en) * 2006-05-19 2007-11-29 Historx, Inc. Kits and methods for evaluating misfolded proteins
EP2209890A4 (en) * 2006-12-13 2011-11-02 Tgr Biosciences Pty Ltd STIMULATION OF PRODUCTION OF EXTRACELLULAR MEDIA WITH FIBROBLAST CELLS AND / OR STIMULATION OF MIGRATION OF FIBROBLAST CELLS IN A BIOLOGICAL SYSTEM
EP2252325A4 (en) * 2008-03-12 2012-07-11 Amicus Therapeutics Inc TREATMENT OF MORBUS POMPE WITH SPECIFIC PHARMACOLOGICAL CHAPTERONES AND TREATMENT MONITORING WITH SURROGATE MARKERS
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
GB201114909D0 (en) * 2011-08-30 2011-10-12 San Raffaele Centro Fond Biomarkers for lysosomal storage disorders
US8293487B1 (en) * 2012-01-06 2012-10-23 Jiandi Zhang Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process
US9983200B2 (en) 2013-03-14 2018-05-29 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
US12020820B1 (en) 2017-03-03 2024-06-25 Cerner Innovation, Inc. Predicting sphingolipidoses (fabry's disease) and decision support
US11335461B1 (en) 2017-03-06 2022-05-17 Cerner Innovation, Inc. Predicting glycogen storage diseases (Pompe disease) and decision support
US11923048B1 (en) 2017-10-03 2024-03-05 Cerner Innovation, Inc. Determining mucopolysaccharidoses and decision support tool

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
AU2990692A (en) 1991-12-06 1993-06-10 Commonwealth Scientific And Industrial Research Organisation Diagnostic method for pompe's disease
CA2147887A1 (en) * 1992-10-30 1994-05-11 James W. Dennis Method for measuring glycosyltransferase activity

Also Published As

Publication number Publication date
CA2253875C (en) 2011-02-22
JP2001519894A (ja) 2001-10-23
JP2006061161A (ja) 2006-03-09
CA2253875A1 (en) 1997-11-27
JP2008289501A (ja) 2008-12-04
US6759189B1 (en) 2004-07-06
IL127033A0 (en) 1999-09-22
JP4260152B2 (ja) 2009-04-30
US20040191847A1 (en) 2004-09-30
WO1997044668A1 (en) 1997-11-27
EP1021725B1 (en) 2009-03-18
ATE426169T1 (de) 2009-04-15
EP1021725A1 (en) 2000-07-26
CA2731490A1 (en) 1997-11-27
DE69739317D1 (de) 2009-04-30
IL127033A (en) 2000-12-06
JP3837711B2 (ja) 2006-10-25
EP1021725A4 (en) 2002-10-30
AUPN991796A0 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
WO1998035985B1 (en) Protein markers for lung cancer and use thereof
WO2001043764A3 (en) Methods for treating pervasive development disorders
IL149171A0 (en) Elisa for vegf
IL127964A0 (en) A method for determining the efficacy of active agents
WO1998053076A3 (en) Compounds for diagnosis of tuberculosis and methods for their use
WO2003077836A3 (en) Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
WO2002014537A3 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
WO1998016645A3 (en) Compounds and methods for diagnosis of tuberculosis
AU5505198A (en) Methods for diagnosis of allergic bronchopulmonary aspergillosis
CA2271544A1 (en) Method to detect bone and other connective tissue disorders in humans and animals
AU5263190A (en) Method and kit for determining tyrosine-phosphorylating and dephosphorylating activities
DE60035267D1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
CA2019872A1 (en) Method and kit for determining the functional activity of protein s in human plasma
FR2722508B1 (fr) Cassette d'expression d'une proteine p30 de toxoplasma gondii
DE50303798D1 (de) Vorrichtung, um in einem Zielgebiet eines menschlichen oder tierischen Körpers einen künstlichen isolierten Kreislauf zu etablieren
WO1999015659A3 (en) Human ubiquitin-conjugating enzymes
FI920669A0 (fi) Reagens foer detektion av fibrinolytisk aktivitet.
CA2415923A1 (en) Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
WO1999027366A3 (en) Method of detecting prostate specific antigen activation peptide
RU98105988A (ru) Способ диагностики гипергликемической комы в постмортальном периоде
EP0213595A3 (en) New transferrins and use thereof
DE69027441D1 (en) Ribozymenhemmer
WO2003038051A3 (en) Method of inducing apoptosis in hyperproliferative cells
GB2289125A (en) Methods of assaying data-repairing enzymes and their alkylated derivatives

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired